Why the study?
Does chronic rapid atrial pacing to maintain atrial fibrillation improve ventricular rate control and heart failure symptoms in a patient with medically refractory incessant atrial tachycardia?
Does chronic rapid atrial pacing to maintain atrial fibrillation improve ventricular rate control and heart failure symptoms in a patient with medically refractory incessant atrial tachycardia?
Chronic rapid atrial pacing can be used to intentionally maintain atrial fibrillation, allowing for pharmacological control of ventricular rate and improvement of tachycardia-induced cardiomyopathy in selected refractory cases.
Answers are grounded in this paper and cite their sources.
May support intentional rapid atrial pacing for rate control in refractory atrial tachycardia; hypothesis-generating and requires prospective validation.
LR was a patient, followed over a 16-year period, who presented with an atrial tachycardia which was initially intermittent, but became incessant. Neither the atrial tachycardia nor the associated rapid ventricular response rate could be treated successfully with available drug therapy, resulting in a dilated cardiomyopathy and New York Heart Association (NYHA) class III-IV congestive heart failure. Acute induction of atrial fibrillation with rapid atrial pacing demonstrated that the associated ventricular rate could be satisfactorily slowed with digitalis therapy. Initially, short bursts from an implanted, radiofrequency controlled, patient activated pacemaker programmed to a rate of 600 bpm and connected to a permanent endocardial atrial J lead successfully interrupted the tachycardia and precipitated atrial fibrillation. Over a period of 3 months, this therapy changed the patient's heart failure to NYHA class II status. Subsequently, precipitation of atrial fibrillation with this technique failed, resulting in return to NYHA class III-IV congestive heart failure. Therefore, a custom-designed, high rate, rate-programmable pacemaker was implanted to pace the atria rapidly and continuously to maintain atrial fibrillation. A pacing rate of 375 bpm plus digoxin slowed the ventricular rate to 70-80 bpm, with stabilization of the congestive heart failure to NYHA class II. The pacemaker generator was replaced 6 months later, and after another 5 months, pacing was discontinued. The patient's subsequent rhythm remained stable atrial fibrillation with clinically successful control of both the ventricular rate and heart failure (NYHA class II) until the patient's death 72 months later. This unique case demonstrates another form of chronic therapy which, in selected cases, can be used for the long term control of rapid ventricular response rates to supraventricular arrhythmia.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: